Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined “liquid biopsy,” epigenetic alterations and machine learning to develop a blood test to detect and classify cancer at its earliest stages.
The findings, published online today in Nature, describe not only a way to detect cancer, but hold promise of being able to find it earlier when it is more easily treated and long before symptoms ever appear, says Dr. De Carvalho, Senior Scientist at the cancer centre, University Health Network.
“We are very excited at this stage,” says Dr. De Carvalho. “A major problem in cancer is how to detect it early. It has been a ‘needle in the haystack’ problem of how to find that one-in-a-billion cancer-specific mutation in the blood, especially at earlier stages, where the amount of tumour DNA in the blood is minimal.”
By profiling epigenetic alterations instead of mutations, the team was able to identify thousands of modifications unique to each cancer type. Then, using a big data approach, they applied machine learning to create classifiers able to identify the presence of cancer-derived DNA within blood samples and to determine what cancer type. This basically turns the “one needle in the haystack” problem into a more solvable “thousands of needles in the haystack,” where the computer just needs to find a few needles to define which haystack has needles.
The scientists tracked the cancer origin and type by comparing 300 patient tumour samples from seven disease sites (lung, pancreatic, colorectal, breast, leukemia, bladder and kidney) and samples from healthy donors with the analysis of cell-free DNA circulating in the blood plasma. In every sample, the “floating” plasma DNA matched the tumour DNA. The team has since expanded the research and has now profiled and successfully matched more than 700 tumour and blood samples from more cancer types.
Beyond the lab, next steps to further validate this approach include analysing data from large population health research studies already under way in several countries, where blood samples were collected months to years before cancer diagnosis. Then the approach will need to be ultimately validated in prospective studies for cancer screening.
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- McMaster, Brock create hand-held device that can diagnose cancer in minutes — and from homeon October 8, 2020 at 2:25 pm
narrow sample strip on another — is heralded as a paradigm shift for personalized medicine and accessible cancer diagnostic testing. It works much like a monitor that a diabetic would use to test ...
- ‘Black breasts matter’: Black women speak out about breast cancer riskon October 8, 2020 at 2:18 pm
The day before she turned 30 and had planned to leave for a celebratory vacation, Sharonda Vincent felt a lump on her left breast while in the shower. She scheduled a last-minute appointment with a ...
- Coping with Metastatic Breast Cancer in the Age of COVID-19on October 8, 2020 at 10:25 am
The COVID-19 pandemic may pose particular challenges if you live with metastatic breast cancer. Find out what to do to get the care you need during this time.
- COVID-19 and canceron October 8, 2020 at 10:13 am
A survey of dozens of clinical investigators in March found that nearly 60 percent of respondents had halted screening and/or enrollment in certain trials, and that half of their institutions had ...
- New study sheds light on the best drug choices for some patients with advanced breast canceron October 8, 2020 at 6:57 am
Patients with metastatic breast cancer carrying a particular mutation fare better on one form of hormone therapy than another and can be identified using a blood test, according to a new study.
- A bandage with magnetic nanofibres that kills skin cancer cells with heaton October 8, 2020 at 6:56 am
Researchers from the Indian Institute of Science (IISc) have developed a non-invasive bandage made with magnetic nanofibres to treat skin cancer by administering heat to the tumor cells.
- Michigan PFAS activist has cancer, says she's not surprisedon October 8, 2020 at 4:08 am
A woman who was honored by the federal government for her environmental activism in western Michigan has been diagnosed with cancer.
- What coverage does Medicare provide for bladder cancer?on October 6, 2020 at 4:54 am
Medicare covers treatment and services relating to bladder cancer. Some out-of-pocket costs may apply. Read on for more information.
- Covid-19: NHS tests threatened by Roche supply chain failingon October 5, 2020 at 5:00 pm
Covid swabs and key tests including those for cancer could run short after problems at diagnostics firm Roche.
via Bing News